Farmak JSC increased its medicine sales by 18.35%
Farmak JSC increased sales of medicines by 18.35%
According to the results of Q1 2018, Farmak JSC increased its sales by 18.35% to 1.1 billion UAH against Q1 2017. Proxima Research data.
“For eight years straight now Farmak has been the leader on the pharmaceutical market of the country*. The company has achieved such results due to quality and innovation. Over the past seven years Farmak has spent 2.8 billion hryvnyas on the development and modernization of production. Today, all the equipment of the Company is high-tech and ultra-modern. Production lines meet GMP, ISO requirements. Farmak’s focus is the manufacture of innovative biotech products. These include Flenox, insulin and its analogues, X-ray contrast agents. At the same time, we continue to produce basic drugs that have been on the market for a few decades,” said Volodymyr Kostiuk, acting Executive Director of Farmak JSC.
Awarding of the corporate media of Ukraine was held on 5 November in Kyiv. Farmak JSC received as much as 4 awards in different categories. The award ceremony was held by the Association of Corporate Media. Overall, 119 works from various domestic and foreign companies took part in the competition.
The Company obtained the Import Export Award 2017 On August 23, the Business Fest for economy leaders organized by the National Business Rating took place on the occasion of the Independence Day of Ukraine. At the event, Farmak JSC obtained the Import Export Award 2017 as the best exporter/importer among Ukrainian companies. The rating program […]
The rating is published by The Top-100. Ratings of the Largest magazine The Top-100. Ratings of the Largest magazine prepared by Delo.UA team has determined Ukraine’s 300 top managers. Volodymyr Kostiuk, Executive Director of Farmak JSC, is in top-20 and has become the best senior manager among the representatives of pharmaceutical companies. He is also [&he...